Julie Bennett — ASN Events
  1. Schedule
  2. Julie Bennett

Julie Bennett

University of Otago, NZ, New Zealand

  • This delegate is presenting an abstract at this event.
Associate Professor Julie Bennett is based in the Department of Public Health, University of Otago, Wellington, New Zealand. She has a wide range of public health research interests, with a particular focus on infectious diseases, indoor air quality, housing and health. Her research activities currently have a strong focus on group A streptococcal infections, acute rheumatic fever and rheumatic heart disease. Julie is the lead researcher of SCIP RHD, a Trans-Tasman collaboration trialing subcutaneous infusions of benzathine penicillin for prevention of rheumatic heart disease. Julie is a member of Pū Manawa (Rheumatic fever network Aotearoa New Zealand) and the World Health Organization ARF and RHD guideline development group.
Presentations this author is a contributor to:

High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics (116419)

10:03 AM
Julie Bennett
Plenary 5 - Interventions for Prevention

Setting the scene for Group A Streptococcus vaccine studies: The complete clinical spectrum of severe acute disease is present in Auckland, Aotearoa New Zealand (#117)

5:30 PM
Andrew Fox-Lewis
Poster Session 1

Human serological assays characterization to evaluate the response against Group A Streptococcus vaccine in clinical trial sera (#194)

5:30 PM
Omar Rossi
Poster Session 1

Subcutaneous injections of penicillin: Convenient and effective treatment for Māori, Pacific Peoples and their whānau in preventing rheumatic heart disease (#273)

5:30 PM
Julie Cooper
Poster Session 2

Growing evidence for Group A Streptococcus skin infections as a cause of acute rheumatic fever (117843)

9:42 AM
Michael G Baker
Plenary 7 - Autoimmunity and Its Long Tail

Tracking the relationship between community Strep A infections and Acute Rheumatic Fever in Auckland, New Zealand: 2018-2024 (#103)

5:30 PM
Julie Bennett
Poster Session 1

"iSOoTH: A study on children's sore throats to inform the development of a Group A Streptococcal vaccine (#166)

5:30 PM
Julie Bennett
Poster Session 1

Immune Responses In Siblings With Acute Rheumatic Fever – A Case Study (#219)

5:30 PM
Natalie Lorenz
Poster Session 2

System Serology Reveals Correlates of Functional Group A Streptococcus Antibody Responses In Children With Pharyngitis (#185)

5:30 PM
Reuben McGregor
Poster Session 1

Autoantigen biomarker discovery for acute rheumatic fever: Application of protein fragment bead arrays to cohort studies in Aotearoa New Zealand and Australia (118403)

10:06 AM
Lauren Carlton
Plenary 7 - Autoimmunity and Its Long Tail

Profiling inflammatory resolution over 6 months in acute rheumatic fever (#222)

5:30 PM
Francis M Middleton
Poster Session 2

Building laboratory capacity to advance Strep A vaccine development in Aotearoa New Zealand (#189)

5:30 PM
Aimee Paterson
Poster Session 1

Identification of a perturbed T cell compartment that underlies rheumatic fever pathogenesis in a trans-Tasman study (118448)

12:20 PM
Francis M Middleton
Plenary 2 - New Insights and New Tools

The Emergence and Impact of M1UK on Invasive Group A Streptococcus Disease in Aotearoa New Zealand (#154)

5:30 PM
Anna Vesty
Poster Session 1

Rapua te mea nagro ka tau- a qualitative, Indigenous-informed approach to vaccine development. (118028)

2:42 PM
Anneka Anderson
Plenary 3 - Big Picture Vaccine Development

Rapua te mea ngaro ka tau: culturally responsive governance applied to vaccine development (#277)

5:30 PM
Shannon Leilua
Poster Session 2

Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand (#146)

5:30 PM
Anna P Ralph
Poster Session 1